126 related articles for article (PubMed ID: 30989099)
1. Rare presentation of disseminated follicular lymphoma as an ill-defined reticular patch over the scalp and forehead.
Talebi-Liasi F; Sandhu S
JAAD Case Rep; 2019 Apr; 5(4):319-322. PubMed ID: 30989099
[No Abstract] [Full Text] [Related]
2. Atypical clinical presentation of primary and secondary cutaneous follicle center lymphoma (FCL) on the head characterized by macular lesions.
Massone C; Fink-Puches R; Cerroni L
J Am Acad Dermatol; 2016 Nov; 75(5):1000-1006. PubMed ID: 27380773
[TBL] [Abstract][Full Text] [Related]
3. Primary cutaneous large B-cell lymphoma of scalp: Case report of a rare variant.
Khatib Y; Dande M; Patel RD; Makhija M
Indian J Pathol Microbiol; 2017; 60(2):268-271. PubMed ID: 28631652
[TBL] [Abstract][Full Text] [Related]
4. A Case of Transformation of Primary Cutaneous Follicle Center Lymphoma to Diffuse Large B-Cell Lymphoma Involving the Parotid Gland and Cervical Lymph Nodes.
King ML; Vengaloor Thomas T; Albert AA; Joseph S; Ramachandran Nair L; Lam JT; Woods WC; Nittala M; Vijayakumar S
Am J Case Rep; 2019 Aug; 20():1273-1278. PubMed ID: 31462626
[TBL] [Abstract][Full Text] [Related]
5. Double-hit lymphomas constitute a highly aggressive subgroup in diffuse large B-cell lymphomas in the era of rituximab.
Kobayashi T; Tsutsumi Y; Sakamoto N; Nagoshi H; Yamamoto-Sugitani M; Shimura Y; Mizutani S; Matsumoto Y; Nishida K; Horiike S; Asano N; Nakamura S; Kuroda J; Taniwaki M
Jpn J Clin Oncol; 2012 Nov; 42(11):1035-42. PubMed ID: 22984125
[TBL] [Abstract][Full Text] [Related]
6. Double-Hit and Triple-Hit Follicular Lymphoma.
Ziemba JB; Wolf Z; Weinstock M; Asakrah S
Am J Clin Pathol; 2020 Apr; 153(5):672-685. PubMed ID: 32112707
[TBL] [Abstract][Full Text] [Related]
7. Spotlight on rituximab in chronic lymphocytic leukemia, low-grade or follicular lymphoma, and diffuse large B-cell lymphoma.
Keating GM
BioDrugs; 2011 Feb; 25(1):55-61. PubMed ID: 21222497
[TBL] [Abstract][Full Text] [Related]
8. Cutaneous double-hit B-cell lymphoma: an aggressive form of B-cell lymphoma with a propensity for cutaneous dissemination.
Magro CM; Wang X; Subramaniyam S; Darras N; Mathew S
Am J Dermatopathol; 2014 Apr; 36(4):303-10. PubMed ID: 23907319
[TBL] [Abstract][Full Text] [Related]
9. Rituximab in the treatment of primary cutaneous B-cell lymphoma: a review.
Fernández-Guarino M; Ortiz-Romero PL; Fernández-Misa R; Montalbán C
Actas Dermosifiliogr; 2014 Jun; 105(5):438-45. PubMed ID: 23540593
[TBL] [Abstract][Full Text] [Related]
10. Survival outcomes of diffuse large B-cell lymphoma by association with concurrent or antecedent follicular lymphoma and double hit status.
Behdad A; Boddy CS; Fought AJ; Taxter T; Falkiewicz MK; Ayers E; Chen QC; Chen YH; Karmali R; Pro B; Winter JN; Landsburg DJ; Gordon LI; Kaplan JB
Leuk Lymphoma; 2019 Dec; 60(13):3266-3271. PubMed ID: 31225766
[TBL] [Abstract][Full Text] [Related]
11. High-grade B-cell Lymphoma with
Shestakova A; Rezk S; Ghasemizadeh D; Nael A; Zhao X
Diagnostics (Basel); 2020 Mar; 10(3):. PubMed ID: 32183313
[TBL] [Abstract][Full Text] [Related]
12. Cutaneous b-cell lymphomas of follicular and marginal zone types: use of Bcl-6, CD10, Bcl-2, and CD21 in differential diagnosis and classification.
de Leval L; Harris NL; Longtine J; Ferry JA; Duncan LM
Am J Surg Pathol; 2001 Jun; 25(6):732-41. PubMed ID: 11395550
[TBL] [Abstract][Full Text] [Related]
13. Primary cutaneous B-cell lymphomas: part II. Therapy and future directions.
Suárez AL; Querfeld C; Horwitz S; Pulitzer M; Moskowitz A; Myskowski PL
J Am Acad Dermatol; 2013 Sep; 69(3):343.e1-11; quiz 355-6. PubMed ID: 23957985
[TBL] [Abstract][Full Text] [Related]
14. Double-hit follicular lymphoma with MYC and BCL2 translocations: a study of 7 cases with a review of literature.
Miao Y; Hu S; Lu X; Li S; Wang W; Medeiros LJ; Lin P
Hum Pathol; 2016 Dec; 58():72-77. PubMed ID: 27544800
[TBL] [Abstract][Full Text] [Related]
15. Spontaneous regression of primary cutaneous diffuse large B-cell lymphoma, leg type with significant T-cell immune response.
Graham PM; Richardson AS; Schapiro BL; Saunders MD; Stewart DM
JAAD Case Rep; 2018 May; 4(4):305-309. PubMed ID: 29693055
[TBL] [Abstract][Full Text] [Related]
16. The differential diagnosis between primary cutaneous large B-cell lymphoma and cutaneous follicular lymphoma: prognostic and therapeutic implications.
Fernandez-Flores A; Smucler-Simonovich A; Escalante F; Manjon JA
Am J Dermatopathol; 2011 Dec; 33(8):819-26. PubMed ID: 22042259
[TBL] [Abstract][Full Text] [Related]
17. THERAPY-RELATED T/MYELOID MIXED PHENOTYPE ACUTE LEUKEMIA IN A PATIENT TREATED WITH CHEMOTHERAPY FOR CUTANEOUS DIFFUSE LARGE B CELL LYMPHOMA.
Roberts E; Oncale M; Safah H; Schmieg J
J La State Med Soc; 2016; 168(1):16-20. PubMed ID: 26986862
[TBL] [Abstract][Full Text] [Related]
18. Remarkable remission of a follicular lymphoma treated with rituximab and polychemotherapy (CHOP).
Schmook T; Stockfleth E; Lischner S; Gahn B; Christophers E; Hauschild A
Clin Exp Dermatol; 2003 Jan; 28(1):31-3. PubMed ID: 12558625
[TBL] [Abstract][Full Text] [Related]
19. Cutaneous presentation of follicular lymphomas.
Franco R; Fernández-Vázquez A; Mollejo M; Cruz MA; Camacho FI; García JF; Navarrete M; Piris MA
Mod Pathol; 2001 Sep; 14(9):913-9. PubMed ID: 11557789
[TBL] [Abstract][Full Text] [Related]
20. Primary cutaneous B-cell lymphoma: narrative review of the literature.
Grandi V; Alberti Violetti S; La Selva R; Cicchelli S; Delfino C; Fava P; Fierro MT; Pileri A; Pimpinelli N; Quaglino P; Berti E
G Ital Dermatol Venereol; 2019 Aug; 154(4):466-479. PubMed ID: 29144099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
